Citations to this article

Inhibition of Hageman factor activation
H. L. Nossel, … , M. Drillings, R. Hsieh
H. L. Nossel, … , M. Drillings, R. Hsieh
Published May 1, 1968
Citation Information: J Clin Invest. 1968;47(5):1172-1180. https://doi.org/10.1172/JCI105806.
View: Text | PDF
Research Article

Inhibition of Hageman factor activation

Abstract

A method for studying inhibitors of the contact stages of blood coagulation is described. A number of positively charged substances were shown to inhibit the contact stages. The inhibitory substances include spermine, cytochrome c, ribonuclease, and lysozyme. The inhibitory effect of these substances was neutralized by the addition of an activated plasma thromboplastin antecedent, factor XI, (PTA) fraction. Other positively charged substances including protamine, hexadimethrine, polylysine, polyornithine, methylene blue, and ortho-toluidine blue also inhibited the contact stages of coagulation, but the inhibitory effect on coagulation was not neutralized by the activated PTA fraction. Negatively charged substances such as heparin and insulin did not inhibit the contact stages of coagulation.

Authors

H. L. Nossel, H. Rubin, M. Drillings, R. Hsieh

×

Total citations by year

Year: 2018 2015 2014 2011 1999 1993 1992 1991 1987 1985 1984 1983 1981 1980 1979 1977 1976 1975 1974 1973 1972 1971 1970 1969 1968 Total
Citations: 1 1 1 1 1 1 2 1 2 1 3 1 1 2 2 3 3 2 5 3 5 6 5 4 1 58
Citation information

Citations to this article (58)

Title and authors Publication Year
Effect of an activated charcoal product (DOAC Stop™) intended for extracting DOACs on various other APTT-prolonging anticoagulants
T Exner, M Ahuja, L Ellwood 		Clinical Chemistry and Laboratory Medicine 2018
Ex vivo neutralization of unfractionated heparin for assessing overall haemostatic potential in patient plasma
M Božič-Mijovski, M Vučnik, V Boc, A Blinc, M Stegnar 		Thrombosis Research 2015
Molecular mechanisms of thrombosis. Fundamental and applied aspects of the contact activation
VN Kolyadko, VA Korneeva, FI Ataullakhanov, MA Panteleev 		2014
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné 		Advances in Immunology Volume 110 2011
Hämostaseologie
G Müller-Berghaus, B Pötzsch 		Hämostaseologie 1999
Inhibition of the activation of hageman factor (factor XII) by eosinophils and eosinophilic constituents
OD Ratnoff, GJ Gleich, SB Shurin, J Kazura, B Everson, P Embury 		American Journal of Hematology 1993
Prekallikrein activation in human, bovine, and rabbit plasmas: Presence of an inhibitor in bovine plasma
KM Weerasinghe 		Inflammation 1992
Inhibition of prekallikrein activation in human plasma by components of bovine plasma
KM Weerasinghe, EP Kirby 		Inflammation 1992
Activation of Complement Kallikrein-kinin, Fibrinolysis and Coagulation Systems by Urinary Catheters. Effect of Time and Temperature in Biocompatibility Studies
PA Siemssen, P GARRED, J OLSEN, AO Aasen, TE Mollnes 		British Journal of Urology 1991
Experimental arthritis induced by polysaccharide macromolecules
RK Aaron, CB Sledge, S Shortkroff 		Arthritis & Rheumatism 1987
The New Dimensions of Warfarin Prophylaxis
S Wessler, CG Becker, Y Nemerson 		1987
Progress in Medicinal Chemistry
JR Brown, SH Imam 		Progress in Medicinal Chemistry 1985
Hymie Nossel (11 July 1930 – 8 October 1983)
KL Kaplan, RE Canfield 		Thrombosis Research 1984
Inhibition of the cerebroside sulphate (sulphatide)-induced contact activation reactions by platelet factor four
KM Weerasinghe, MF Scully, VV Kakkar 		Thrombosis Research 1984
Contemporary Topics in Polymer Science
WJ Bailey, T Tsuruta 		1984
A platelet derived inhibitor of plasma prekallikrein activation
KM Weerasinghe, MF Scully, VV Kakkar 		Thrombosis Research 1983
Hydrophilization of polymer surfaces by synthetic polyelectrolytes and their complexes
NA Plate, YD Aliyeva, AA Kalachev 		Polymer Science U.S.S.R. 1981
A proteaselike permeability factor in guinea pig skin: contact activation of the latent permeability factor and its nature as a prekallikrein activator
K Kozono, T Yamamoto, T Kambara 		The American Journal of Pathology 1980
Inhibition of contact activation by platelet factor 4
MF Scully, K Weerasinghe, VV Kakkar 		Thrombosis Research 1980
Anticoagulant peptides obtained from human fibrinogen degradation products by plasmin
K Takagi, S Suzuki, T Kawai 		Thrombosis Research 1979
Molecular assembly in the contact phase of the Hageman factor system
CG Cochrane, JH Griffin 		The American Journal of Medicine 1979
Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein
RC Wiggins, BN Bouma, CG Cochrane, JH Griffin 		Proceedings of the National Academy of Sciences 1977
Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein
O Sachiko, K Makoto, YN Han, I Sadaaki, K Hisao, S Tomoji 		Biochemical Pharmacology 1977
MATERIALS WITH CHEMICALLY ACTIVE SUBSTITUENTS
RD Falb, RI Leininger, JP Crowley 		Annals of the New York Academy of Sciences 1977
The induction of macrophage spreading: role of coagulation factors and the complement system
C Bianco, A Eden, ZA Cohn 		Journal of Experimental Medicine 1976
New evidence for the activation of factor XII by epinephrine
DM Zubairov, LG Popova 		Thrombosis Research 1976
THE LACK OF DETECTABLE IMMUNE COMPLEXES IN RAT ANAPHYLAXIS
L FéSüS, M Kavai 		Allergy 1976
Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin
PC Harpel, NR Cooper 		Journal of Clinical Investigation 1975
Experimental Production of Diseases: Heart and Circulation
J Schmier, O Eichler 		1975
Preparation, Characterization, and Activation of a Highly Purified Factor XI: Evidence that a Hitherto Unrecognized Plasma Activity Participates in the Interaction of Factors XI and XII
S Schiffman, P Lee 		British Journal of Haematology 1974
Activation of Hageman factor and initiation of hepatic vein thrombosis in the hyperlipemic rat
JG Latour, C Léger, S Renaud 		The American Journal of Pathology 1974
Soluble mediators of injury of the microvasculature: Hageman factor and the kinin forming, intrinsic clotting and the fibrinolytic systems
CG Cochrane, SD Revak, KD Wuepper, A Johnston, DC Morrison, R Ulevitch 		Microvascular Research 1974
Lysozyme
HS Gilbert 		Lysozyme 1974
Brief Reviews: Some Recent Advances in the Study of Hemostasis
OD Ratnoff 		Circulation research 1974
Degradation of Human Fibrinogen by Plasma α2-Macroglobulin-Enzyme Complexes
PC Harpel, MW Mosesson 		Journal of Clinical Investigation 1973
The Influence of Haemoglobin on the Fibrinolytic Enzyme System
D Ogston, RJ Herbert 		Scandinavian Journal of Haematology 1973
Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein
CG Cochrane, SD Revak, KD Wuepper 		Journal of Experimental Medicine 1973
Plasma prekallikrein: isolation, characterization, and mechanism of activation
KD Wuepper, CG Cochrane 		Journal of Experimental Medicine 1972
What factors determine thrombogenicity
L Vroman 		Bulletin of the New York Academy of Medicine 1972
The Role of Platelets in the Contact Phase of Blood Coagulation
PN Walsh 		British Journal of Haematology 1972
The Effect of Dilution of Plasma on Coagulation: The Significance of the Dilution-Activation Phenomenon for the Study of Platelet Coagulant Activities
PN Walsh 		British Journal of Haematology 1972
Effects of protamine sulfate, polybrene and heparin on the behavior of plasma, plasma proteins, platelets and factor XII activity at interfaces
M Klings, AL Adams, L Vroman 		Thrombosis Research 1972
Radioimmunoassay of human fibrinopeptide A
HL Nossel, LR Younger, GD Wilner, T Procupez, RE Canfield, VP Butler 		Proceedings of the National Academy of Sciences 1971
Activation of Coagulation by Heparin-Protamine Complexes as Demonstrated by Thrombotest
HC Godal, G Gjengedal 		Scandinavian Journal of Haematology 1971
Hemoglobin, inhibitor of the contact phase of blood coagulation
E Triantaphyllopoulos 		Life Sciences 1971
Thrombosis and Bleeding Disorders
EF Mammen 		Thrombosis and Bleeding Disorders 1971
Hageman Factor Activation in the Generalized Shwartzman Reaction Induced by Endotoxin
G Müller-Berghaus, R Schneberger 		British Journal of Haematology 1971
Hypercoagulable states in pregnancy
DE Reid, FD Frigoletto, JL Tullis, J Hinman 		American Journal of Obstetrics and Gynecology 1971
Local and systemic factors in the pathogenesis of thrombosis
D Deykin 		California medicine 1970
Coagulation and fibrinolysis after injury
PT Flute 		Journal of clinical pathology. Supplement (Royal College of Pathologists) 1970
Glass-activated plasma kallikrein
OB Henriques, V Stolpnik, V Kusnetsova, M Astrakan 		Biochemical Pharmacology 1970
Endotoxin-induced kinin (bradykinin) formation: Activation of Hageman factor and plasma kallikrein in human plasma
WA Pettinger, R Young 		Life Sciences 1970
The Relation of ‘Fletcher Factor’ to Factors XI and XII
WE Hathaway, J Alsever 		British Journal of Haematology 1970
Electrosorption of amino acids peptides and proteins in relation to the compatibility of materials and the human body
GE Stoner 		Journal of Biomedical Materials Research 1969
Importances of Polar Groups for initiating Blood Coagulation and aggregating Platelets
HL Nossel, GD Wilner, EC Leroy 		Nature 1969
Defibrination syndrome in a patient with chronic thrombocytopenic purpura
HL Nossel, J Niemetz, SA Waxman, SL Spector 		The American Journal of Medicine 1969
Effect of heparin on reactions at aminated polymer—blood interfaces
L Vroman, AL Adams 		Journal of Colloid and Interface Science 1969
Activation of hageman factor by collagen
GD Wilner, HL Nossel, EC LeRoy 		Journal of Clinical Investigation 1968

Advertisement